|
UBE4A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.630000E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.425200E-01 |
| Normal-vs-Stage2 |
2.052200E-01 |
| Normal-vs-Stage3 |
1.278060E-03 |
| Normal-vs-Stage4 |
1.759750E-03 |
| Stage1-vs-Stage2 |
5.918400E-01 |
| Stage1-vs-Stage3 |
9.018500E-03 |
| Stage1-vs-Stage4 |
6.164500E-03 |
| Stage2-vs-Stage3 |
3.170400E-01 |
| Stage2-vs-Stage4 |
1.918830E-01 |
| Stage3-vs-Stage4 |
5.910200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.154000E-02 |
| Normal-vs-AfricanAmerican |
4.563800E-04 |
| Normal-vs-Asian |
5.326000E-01 |
| Caucasian-vs-AfricanAmerican |
1.707720E-02 |
| Caucasian-vs-Asian |
8.791000E-01 |
| AfricanAmerican-vs-Asian |
2.454600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.530110E-02 |
| Normal-vs-Female |
1.154600E-01 |
| Male-vs-Female |
2.094000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.935500E-02 |
| Normal-vs-Age(41-60Yrs) |
3.493000E-01 |
| Normal-vs-Age(61-80Yrs) |
4.644000E-04 |
| Normal-vs-Age(81-100Yrs) |
8.287700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.762560E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.984400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.070800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.735940E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.088400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.348000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.150000E-01 |
| Normal-vs-Grade 2 |
3.743400E-01 |
| Normal-vs-Grade 3 |
2.336500E-03 |
| Normal-vs-Grade 4 |
9.98460000000145E-05 |
| Grade 1-vs-Grade 2 |
2.878600E-01 |
| Grade 1-vs-Grade 3 |
1.622040E-02 |
| Grade 1-vs-Grade 4 |
5.837100E-03 |
| Grade 2-vs-Grade 3 |
8.499400E-03 |
| Grade 2-vs-Grade 4 |
3.045900E-04 |
| Grade 3-vs-Grade 4 |
4.030200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.079400E-01 |
| Normal-vs-ccB subtype |
8.163900E-04 |
| ccA subtype-vs-ccB subtype |
2.85349999995521E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.847700E-02 |
| Normal-vs-N1 |
7.557500E-03 |
| N0-vs-N1 |
1.062170E-01 |
|
|
